QURE Insider Trading Activity and SEC Form 4 Filings
QURE insider trading summary
Over the past 12 months, insiders at uniQure N.V. (QURE) reported 47 sales worth $17.7M by 12 insiders and no open-market purchases on SEC Form 4. Net insider selling was $17.7M.
Latest QURE insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jul 2, 2026 | Matthew C Kapusta | CEO, Managing Director | Sell | $409K (9,200 @ $44.43) |
| Jul 2, 2026 | Matthew C Kapusta | CEO, Managing Director | Sell | $349K (7,600 @ $45.89) |
| Jul 2, 2026 | Matthew C Kapusta | CEO, Managing Director | Sell | $195K (4,282 @ $45.43) |
| Jun 30, 2026 | Walid Abi-Saab | Chief Medical Officer | Sell | $465K (10,000 @ $46.46) |
| Jun 30, 2026 | Jack Kaye | Director | Sell | $792K (17,060 @ $46.43) |
| Jun 30, 2026 | Walid Abi-Saab | Chief Medical Officer | Sell | $928K (20,000 @ $46.40) |
| Jun 30, 2026 | Jack Kaye | Director | Sell | $191K (4,107 @ $46.49) |
| Jun 26, 2026 | Walid Abi-Saab | Chief Medical Officer | Sell | $67K (1,434 @ $46.86) |
| Jun 18, 2026 | Matthew C Kapusta | CEO, Managing Director | Sell | $1.9M (37,015 @ $50.00) |
| Jun 18, 2026 | Matthew C Kapusta | CEO, Managing Director | Sell | $233K (4,656 @ $50.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.